Biogen Inc.
DE ˙ DB ˙ US09062X1037
162,20 € ↑3,64 (2,30%)
2026-06-03
AKTIENPREIS
SecurityDE:IDP / Biogen Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership12,506,681 shares
Ownership 8.50%
BlackRock, Inc. ownership in IDP / Biogen Inc.

2025-04-17 - BlackRock, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 12,506,681 shares of Biogen Inc. (DE:IDP). This represents 8.5 percent ownership of the company. In their previous filing dated 2024-08-07 , BlackRock, Inc. had reported owning 14,646,751 shares, indicating a decrease of -14.61 percent.

BlackRock, Inc. has a history of taking positions in derivatives of the underlying security (IDP) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2025-04-17 2025-04-17 13G/A 14,646,751 12,506,681 -14.61 8.50 -15.84
2024-08-07 2024-08-07 13G/A 14,246,320 14,646,751 2.81 10.10 3.06
2024-01-24 2024-01-24 13G/A 14,260,137 14,246,320 -0.10 9.80 -1.01
2023-01-24 2023-01-24 13G/A 13,736,954 14,260,137 3.81 9.90 5.32
2022-03-07 2022-03-07 13G/A 13,736,954 13,736,954 0.00 9.40 0.00
2022-02-08 2022-02-08 13G 13,419,601 13,736,954 2.36 9.40 8.05
2021-01-29 2021-01-29 13G/A 15,658,641 13,419,601 -14.30 8.70 0.00
2021-01-29 2021-01-29 13G/A 13,419,601 13,419,601 0.00 8.70 0.00
2020-02-05 2020-02-05 13G/A 16,568,963 15,658,641 -5.49 8.70 6.10
2019-02-04 2019-02-04 13G/A 16,804,682 16,568,963 -1.40 8.20 3.80
2018-01-29 2018-01-29 13G/A 17,082,146 16,804,682 -1.62 7.90 0.00
2017-01-19 2017-01-19 13G/A 16,712,457 17,082,146 2.21 7.90 5.33
2016-02-10 2016-02-10 13G/A 16,712,457 7.50
2015-01-29 2015-01-29 13G/A 15,356,403 6.50
2014-02-04 2014-02-04 13G/A 14,185,116 6.00
2013-02-08 2013-02-08 13G/A 12,771,880 5.40
2012-02-13 2012-02-13 13G/A 17,256,111 7.10

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:IDP / Biogen Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F BIOGEN COM 09062X103 15,974,601 1,163,231 7.85 2,928,623 12.35 0.0512
2026-02-12 2025-12-31 13F BIOGEN COM 09062X103 14,811,370 47,418 0.32 2,606,653 26.04 0.0441
2025-11-12 2025-09-30 13F BIOGEN COM 09062X103 14,763,952 1,208,486 8.92 2,068,134 21.48 0.0362
2025-08-12 2025-06-30 13F BIOGEN COM 09062X103 13,555,466 -1,655,570 -10.88 1,702,431 -18.21 0.0324
2025-05-02 2025-03-31 13F BIOGEN COM 09062X103 15,211,036 -262,674 -1.70 2,081,478 -12.03 0.0437
2025-02-07 2024-12-31 13F BIOGEN COM 09062X103 15,473,710 126,669 0.83 2,366,240 -20.46 0.0479
2024-11-13 2024-09-30 13F BIOGEN COM 09062X103 15,347,041 808,544 5.56 2,974,870 -11.73 0.0624
2024-08-13 2024-06-30 13F BIOGEN COM 09062X103 14,538,497 393,509 2.78 3,370,314 10.50 0.0763
2024-05-10 2024-03-31 13F BIOGEN COM 09062X103 14,144,988 -101,670 -0.71 3,050,084 -17.27 0.0710
2024-02-13 2023-12-31 13F BIOGEN COM 09062X103 14,246,658 272,071 1.95 3,686,608 2.65 0.0940
2023-11-13 2023-09-30 13F BIOGEN COM 09062X103 13,974,587 -91,407 -0.65 3,591,609 -10.36 0.1033
2023-08-11 2023-06-30 13F BIOGEN COM 09062X103 14,065,994 79,773 0.57 4,006,698 3.04 0.1104
2023-05-12 2023-03-31 13F BIOGEN COM 09062X103 13,986,221 -274,392 -1.92 3,888,589 -1.53 0.1147
2023-02-13 2022-12-31 13F BIOGEN COM 09062X103 14,260,613 413,887 2.99 3,949,049 6.82 0.1237
2022-11-14 2022-09-30 13F BIOGEN COM 09062X103 13,846,726 -616,733 -4.26 3,697,075 25.34 0.1257
2022-08-12 2022-06-30 13F BIOGEN COM 09062X103 14,463,459 342,362 2.42 2,949,675 -0.81 0.0946
2022-05-12 2022-03-31 13F BIOGEN COM 09062X103 14,121,097 399,143 2.91 2,973,904 -9.67 0.0801
2022-02-10 2021-12-31 13F BIOGEN COM 09062X103 13,721,954 -174,299 -1.25 3,292,170 -16.28 0.0838
2021-11-09 2021-09-30 13F BIOGEN COM 09062X103 13,896,253 689,662 5.22 3,932,503 -14.01 0.1101
2021-08-11 2021-06-30 13F BIOGEN COM 09062X103 13,206,591 -296,037 -2.19 4,573,047 21.06 0.1273
2021-05-07 2021-03-31 13F BIOGEN COM 09062X103 13,502,628 83,027 0.62 3,777,361 14.96 0.1110
2021-02-05 2020-12-31 13F BIOGEN COM 09062X103 13,419,601 -1,043,678 -7.22 3,285,921 -19.91 0.1048
2020-11-06 2020-09-30 13F BIOGEN COM 09062X103 14,463,279 -136,177 -0.93 4,102,944 5.04 0.1514
2020-08-14 2020-06-30 13F BIOGEN COM 09062X103 14,599,456 -1,443,581 -9.00 3,906,084 -23.04 0.1559
2020-05-01 2020-03-31 13F BIOGEN COM 09062X103 16,043,037 384,396 2.45 5,075,698 9.24 0.2483
2020-02-13 2019-12-31 13F BIOGEN COM 09062X103 15,658,641 219,594 1.42 4,646,388 29.26 0.1782
2019-11-08 2019-09-30 13F BIOGEN COM 09062X103 15,439,047 -573,590 -3.58 3,594,519 -4.01 0.1510
2019-08-22 2019-06-30 13F/A-1 BIOGEN COM 09062X103 16,012,637 -280,115 -1.72 3,744,875 -2.76 0.1602
2019-08-13 2019-06-30 13F BIOGEN COM 09062X103 16,012,637 -280,115 3,744,875
2019-05-09 2019-03-31 13F BIOGEN COM 09062X103 16,292,752 -276,211 -1.67 3,851,280 -22.76 0.1719
2019-02-08 2018-12-31 13F BIOGEN COM 09062X103 16,568,963 70,603 0.43 4,985,931 -14.46 0.2517
2018-11-09 2018-09-30 13F BIOGEN COM 09062X103 16,498,360 -584,223 -3.42 5,829,036 17.57 0.2522
2018-08-09 2018-06-30 13F BIOGEN COM 09062X103 17,082,583 -185,756 -1.08 4,958,050 4.86 0.2284
2018-05-09 2018-03-31 13F BIOGEN COM 09062X103 17,268,339 463,656 2.76 4,728,416 -11.68 0.2260
2018-02-09 2017-12-31 13F BIOGEN COM 09062X103 16,804,683 -139,606 -0.82 5,353,466 0.90 0.2547
2017-11-14 2017-09-30 13F BIOGEN COM 09062X103 16,944,289 -1,163,069 -6.42 5,305,594 7.98 0.2677
2017-08-10 2017-06-30 13F BIOGEN COM 09062X103 18,107,358 415,099 2.35 4,913,612 1.58 0.2606
2017-05-12 2017-03-31 13F BIOGEN COM 09062X103 17,692,259 17,074,075 2,761.97 4,837,418 2,659.43 0.2655
2017-02-10 2016-12-31 13F BIOGEN COM 09062X103 618,184 32,119 5.48 175,305 -4.44 0.2481
2016-11-08 2016-09-30 13F BIOGEN COM 09062X103 586,065 -63,123 -9.72 183,455 16.86 0.2634
2016-08-10 2016-06-30 13F BIOGEN COM 09062X103 649,188 86,484 15.37 156,987 7.17 0.2362
2016-05-10 2016-03-31 13F BIOGEN COM 09062X103 562,704 -157,354 -21.85 146,483 -33.60 0.2356
2016-02-11 2015-12-31 13F BIOGEN COM 09062X103 720,058 2,480 0.35 220,591 5.35 0.3236
2015-11-13 2015-09-30 13F BIOGEN COM 09062X103 717,578 70,057 10.82 209,397 -19.94 0.3282
2015-08-07 2015-06-30 13F BIOGEN COM 09062X103 647,521 -65,817 -9.23 261,560 -13.16 0.3879
2015-05-13 2015-03-31 13F BIOGEN COM 09062X103 713,338 -5,410 -0.75 301,199 23.45 0.4163
2015-02-09 2014-12-31 13F BIOGEN IDEC COM 09062X103 718,748 14,708 2.09 243,979 4.76 0.3489
2014-10-29 2014-09-30 13F BIOGEN IDEC COM 09062X103 704,040 -53,947 -7.12 232,904 -2.55 0.3404
2014-08-06 2014-06-30 13F BIOGEN IDEC COM 09062X103 757,987 49,426 6.98 239,002 10.28 0.3554
2014-05-02 2014-03-31 13F BIOGEN IDEC COM 09062X103 708,561 40,418 6.05 216,728 16.03 0.3500
2014-02-12 2013-12-31 13F BIOGEN IDEC COM 09062X103 668,143 118,058 21.46 186,793 41.04 0.3049
2013-11-12 2013-09-30 13F BIOGEN IDEC COM 09062X103 550,085 -5,297 -0.95 132,439 10.81 0.2496
2013-08-13 2013-06-30 13F BIOGEN IDEC COM 09062X103 555,382 555,382 119,518 0.2369
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-05-12 2022-03-31 13F BIOGEN OPTIONS Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-10 2021-12-31 13F BIOGEN OPTIONS Call 15,000 3,599 n/a n/a n/a
2017-02-10 2016-12-31 13F BIOGEN OPTIONS Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-11-08 2016-09-30 13F BIOGEN OPTIONS Call 200 63 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2014-08-06 2014-06-30 13F BIOGEN IDEC OPTIONS Put 0 -100.00 0 -100.00 n/a n/a n/a
2014-05-02 2014-03-31 13F BIOGEN IDEC OPTIONS Put 2,900 887 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.